StockData
BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

BIOREGENX, INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$3.88M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Bioregenx has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Bioregenx filed with the SEC

  • FORM 8-K

    Event dated Apr 4, 2025, from SEC EDGAR

  • FORM 8-K

    Event dated Jan 15, 2025, from SEC EDGAR

  • FORM 8-K

    Event dated Oct 7, 2024, from SEC EDGAR

  • CURRENT REPORT

    Event dated Jul 17, 2024, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 13, 2024, from SEC EDGAR

  • FORM 8-K

    Event dated Jun 7, 2024, from SEC EDGAR

  • FORM 8-K

    Event dated May 15, 2024, from SEC EDGAR

  • CURRENT REPORT

    Event dated Mar 8, 2024, from SEC EDGAR

  • Current report on Form 8-K

    Event dated Dec 29, 2022, from SEC EDGAR